Leaderboard
Anzeige
medline.ch
En
|
De
Impressum
No articles selected!
View Cart
You are here:
Urology-Nephrology
»
Neoplasia/BPH
18. May 2026
Search
medline.ch
Neoplasia/BPH
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Inflammation-Infection
Nephrolithiasis
Renal Failure
Sexuality
Neoplasia/BPH
Others
Rect Top
Anzeige
Zoom:
Page 1 of 9397
Articles 1 - 20 / 187921
Risk factors and the impact of comorbidities in patients developing urethral stricture after transurethral resection of the prostate.
World J Urol
U, Atan A, Aytekin C, Koparal MY, Bulut EC, Polat F, Ye.
PMID: 42149232 [PubMed - indexed for MEDLINE]
[Non-muscle-invasive urothelial carcinoma of the bladder: time for a de-escalation of treatment and aftercare].
Urologie
Heidenreich A.
PMID: 42149195 [PubMed - as supplied by publisher]
Dissecting the Tumor Microenvironment to Identify Biomarkers of Outcome to Anti-PD-1 Therapy in Clear Cell Renal Cell Carcinoma: analyses of the HCRN GU16-260 trial.
Clin Cancer Res
El Ahmar N, Paul MA, Simsek B, Matar S, Jegede OA, Laimon YN, Savla V, Mohanna R, de Oliveira GR, Bagheri Sheshdeh A, Denize T, West DJ, Seager MD, Sun M, Choueiri TK, Xie W, Freeman GJ, Sharpe AH, Braun DA, Haas NB, Hammers H, Bilen MA, Stein M, Sosman JA, Wu CJ, McDermott DF, Atkins MB, Signoretti S.
PMID: 42149133 [PubMed - as supplied by publisher]
Association of renal artery variations with aggressive pathological features and poor prognosis in clear-cell renal cell carcinoma: a computed tomography-based three-dimensional reconstruction study.
Quant Imaging Med Surg
Li J, Lv D, Yao X, Sun K, Guo Z, Zhou H, Wang Q, Jia M, Shuang W.
PMID: 42147872 [PubMed]
Multiparametric magnetic resonance imaging (MRI) integrating amide proton transfer-weighted (APTw) imaging, synthetic MRI, and multiplexed sensitivity encoding diffusion-weighted imaging (MUSE DWI) in the diagnosis and grading of prostate cancer.
Quant Imaging Med Surg
Zhao Z, Zhang Q, Shi J, Bao J, Hu C, Qiao X, Zhou M, Wang X.
PMID: 42147861 [PubMed]
Prediction models in prostate cancer: a systematic review and meta-analysis.
Front Oncol
Israel EN, Niels KN, Makanjuola OO, Rotimi OA, Afolabi IS.
PMID: 42147249 [PubMed]
Electrochemical Determination of the Prostate Anti-Cancer Drug Nilutamide Using Gold Nanoparticle-Polymer Based Electrode.
ACS Omega
Karaka, , Elçi A, Karabiberoglu , Dursun Z.
PMID: 42146162 [PubMed]
Metabolic crosstalk in the bladder tumor microenvironment: lactate shuttling, amino acid dependency, and immunosuppression.
Cytotechnology
Lu H, He J, Wang H, Li W, Chang P, Li W.
PMID: 42145840 [PubMed]
Germline polygenic score for prostate cancer aggressiveness.
medRxiv
Xu GJ, Karunamuni R, Dornisch AM, Brunette CA, Danowski ME, Desai H, Dochtermann D, Garraway IP, Hauger RL, Kibel AS, Lynch JA, Pyarajan S, Rose BS, Teerlink CC, Andreassen OA, Dale AM, Donovan JL, Hamdy F, Kachuri L, Lane A, Martin RM, Mills IG, Neal DE, Turner EL, Witte JS, Schleutker J, Pashayan N, Batra J, Australian Prostate Cancer BioResource (APCB), Nordestgaard BG, Hamilton RJ, Wolk A, Albanes D, Atkins J, Blot WJ, Mucci LA, Nielsen SF, Cussenot O, Berndt SI, Koutros S, Sørensen KD, Cybulski C, Menegaux F, Park JY, MacInnis RJ, Rosenstein BS, Lu YJ, Watya S, Vega A, NC-LA PCaP Investigators, IMPACT Study Steering Committee and Collaborators, Kogevinas M, Wiklund F, Plym A, Teixeira MR, Multigner L, Leach RJ, Brenner H, John EM, Kaneva R, Logothetis CJ, Neuhausen SL, Ost P, Razack A, Fowke JH, Gamulin M, Usmani N, Claessens F, Castelao JE, Petrovics G, Parent MÉ, Hu JJ, Zheng W, Profile Study Steering Committee, UKGPCS collaborators, Kote-Jarai Z, Eeles RA, PRACTICAL Consortium, VA Million Veteran Program, Maxwell KN, Vassy JL, Seibert TM.
PMID: 42145622 [PubMed]
Safety of carbon-ion radiotherapy for prostate cancer after rectal surgery: a single-institution retrospective study.
J Radiat Res
Yamaguchi T, Okato A, Wakatsuki M, Miura K, Makishima H, Nakajima M, Sazuka T, Sakamoto S, Ohnishi K, Ichikawa T, Ishikawa H.
PMID: 42145265 [PubMed - as supplied by publisher]
Diabetes mellitus as a potential risk factor for severe late toxicity after stereotactic body radiotherapy for prostate cancer: a large single-institution cohort study.
J Radiat Res
Sugahara D, Yamashita H, Mizumoto H, Ueno H, Kasuga Y, Hayashi T, Yasui A, Sawayanagi S, Nozawa Y, Ogita M.
PMID: 42145256 [PubMed - as supplied by publisher]
Role of androgen receptor signaling in chemoresistance in urothelial cancer: a narrative review.
Chin Clin Oncol
Akai T, Yamamichi G, Miyamoto H.
PMID: 42145004 [PubMed - indexed for MEDLINE]
Enhancing urothelial carcinoma diagnosis with artificial intelligence-integrated urine cytology: Biopsy-validated accuracy and efficiency gain.
Cancer Cytopathol
Lajara S, Cuda J, Geisler DL, Staniszewski C, Yang WL, Atkison K, Lin CY, Shao G, Liu TJ, Crothers B, Dhir R, Khader SN.
PMID: 42144873 [PubMed - indexed for MEDLINE]
Relationship between the status of positive surgical margins and biochemical recurrence: developing a risk stratification model for biochemical recurrence following radical prostatectomy.
J Robot Surg
Morizane S, Hussein AA, Jing Z, Mahmood AW, Wychowski S, Khan S, Das S, Ahmad A, Iskander J, Harrington G, Khan M, Ahmed Z, Howlader M, Takenaka A, Guru KA.
PMID: 42144537 [PubMed - indexed for MEDLINE]
Ultra-hypofractionated stereotactic ablative body radiotherapy for primary renal cell carcinoma: 5-year outcomes from a pooled analysis of the FASTRACK trials.
Lancet Oncol
Siva S, Ali M, Hardcastle N, Kron T, Higgs B, Foroudi F, Ruben J, Appu S, Martin J, Sridharan S, Montgomery R, Davey R, Lin C, Shaw M, Chander S, Sidhom M, Vanneste BGL, Murphy DG, Lawrentschuk N, Pryor D, Wood S, Moon D, Bressel M.
PMID: 42144019 [PubMed - as supplied by publisher]
Long-term outcomes of stereotactic ablative body radiotherapy for primary kidney cancer (TROG 15.03 FASTRACK II): a multicentre, non-randomised, phase 2 study.
Lancet Oncol
Siva S, Pryor D, Martin J, Hardcastle N, Moon D, Kron T, Higgs B, Foroudi F, Ruben J, Sridharan S, Montgomery R, Davey R, Lin C, Shaw M, Lawrentschuk N, Appu S, Vanneste BGL, Hofman MS, Murphy DG, De Abreu Lourenco R, Mancuso P, Brook NR, Raman A, Wong LM, Sidhom M, Wood S, Ali M, Bressel M.
PMID: 42144018 [PubMed - as supplied by publisher]
Shared Decision-Making for Prostate Cancer Screening in Racial and Ethnic Minority Populations: A Systematic Review.
J Racial Ethn Health Disparities
Joung H, Shin H, Jones RA.
PMID: 42143174 [PubMed - as supplied by publisher]
Exploring Lived Experiences of Men Diagnosed With Prostate Cancer in Oman: A Qualitative Study.
Health Expect
Al-Abri K, Al-Louyahi MH, Al-Samani HS, Al-Ghanboosi MJ, Al-Junaibi KH, Al-Adawi NH, Romadlon DS.
PMID: 42142306 [PubMed - indexed for MEDLINE]
Predicting Positive Surgical Margins in Robot-Assisted Prostatectomy Using Machine Learning Models.
Int J Med Robot
Fan G, Chen H, Li Y, Chen Y, Tang T.
PMID: 42142026 [PubMed - indexed for MEDLINE]
Impact of Staged Rehabilitation Training on Urinary Incontinence Recovery After Radical Prostatectomy: A Retrospective Analysis.
Am J Mens Health
Hu Y, Yao L, Liu C, Tian J, Liu A.
PMID: 42141375 [PubMed - indexed for MEDLINE]
Articles 1 - 20 / 187921
Page 1 of 9397
Rect Bottom
Anzeige
Adserver Footer
Time frame
--unlimited--
1 Week
1 Month
3 Months
6 Months
1 Year
2 Years
3 Years
5 Years
10 Years
Sky right 1
Anzeige
Mediscope AG E-mail:
info@mediscope.ch
Disclaimer
|
Privacy Policy